These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 31191535)

  • 1. Interleukin-36 in Infectious and Inflammatory Skin Diseases.
    Buhl AL; Wenzel J
    Front Immunol; 2019; 10():1162. PubMed ID: 31191535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases.
    Ahmad F; Alam MA; Ansari AW; Jochebeth A; Leo R; Al-Abdulla MN; Al-Khawaga S; AlHammadi A; Al-Malki A; Al Naama K; Ahmad A; Buddenkotte J; Steinhoff M
    J Invest Dermatol; 2024 Feb; 144(2):206-224. PubMed ID: 38189700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of interleukin-36 in health and disease states.
    Sugiura K; Fujita H; Komine M; Yamanaka K; Akiyama M
    J Eur Acad Dermatol Venereol; 2024 Oct; 38(10):1910-1925. PubMed ID: 38779986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emergence of the IL-36 cytokine family as novel targets for inflammatory diseases.
    Walsh PT; Fallon PG
    Ann N Y Acad Sci; 2018 Apr; 1417(1):23-34. PubMed ID: 27783881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IL-1 family of cytokines and receptors in rheumatic diseases.
    Dinarello CA
    Nat Rev Rheumatol; 2019 Oct; 15(10):612-632. PubMed ID: 31515542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-36γ and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2.
    Aoyagi T; Newstead MW; Zeng X; Nanjo Y; Peters-Golden M; Kaku M; Standiford TJ
    PLoS Pathog; 2017 Nov; 13(11):e1006737. PubMed ID: 29166668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
    Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
    Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology of IL-36 cytokines and their role in disease.
    Gresnigt MS; van de Veerdonk FL
    Semin Immunol; 2013 Dec; 25(6):458-65. PubMed ID: 24355486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-36 family cytokines in protective versus destructive inflammation.
    Han Y; Huard A; Mora J; da Silva P; Brüne B; Weigert A
    Cell Signal; 2020 Nov; 75():109773. PubMed ID: 32898612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions.
    Sachen KL; Arnold Greving CN; Towne JE
    Cytokine; 2022 Aug; 156():155897. PubMed ID: 35679693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
    Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
    PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function and Regulation of IL-36 Signaling in Inflammatory Diseases and Cancer Development.
    Queen D; Ediriweera C; Liu L
    Front Cell Dev Biol; 2019; 7():317. PubMed ID: 31867327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.
    Towne JE; Renshaw BR; Douangpanya J; Lipsky BP; Shen M; Gabel CA; Sims JE
    J Biol Chem; 2011 Dec; 286(49):42594-42602. PubMed ID: 21965679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.
    Ge Y; Huang M; Yao YM
    Cytokine Growth Factor Rev; 2019 Feb; 45():24-34. PubMed ID: 30587411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting IL-36 in Inflammatory Skin Diseases.
    Fukaura R; Akiyama M
    BioDrugs; 2023 May; 37(3):279-293. PubMed ID: 36867370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and function of interleukin-36 cytokines.
    Bassoy EY; Towne JE; Gabay C
    Immunol Rev; 2018 Jan; 281(1):169-178. PubMed ID: 29247994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interleukin-1 family: back to the future.
    Garlanda C; Dinarello CA; Mantovani A
    Immunity; 2013 Dec; 39(6):1003-18. PubMed ID: 24332029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.
    Palomo J; Dietrich D; Martin P; Palmer G; Gabay C
    Cytokine; 2015 Nov; 76(1):25-37. PubMed ID: 26185894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
    Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions.
    Gabay C; Towne JE
    J Leukoc Biol; 2015 Apr; 97(4):645-52. PubMed ID: 25673295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.